SABOURETCardiologist@SABOURETCardioJun 29, 2022Low levels of #LDLc #ICH and #Safety : final pdf soon online.2020117117382382
SABOURETCardiologist@SABOURETCardioOct 27, 2022I saw a 84 y old pt after discharge with #HFrEF for the first time. What a good surprise to see that the « Fabulous four » already were initiated ☀️16164444385385
SABOURETCardiologist@SABOURETCardioApr 10, 2021May we use #DOAC in #Bioprosthetic mitral valve ? Yes we may.667474248248
SABOURETCardiologist@SABOURETCardioMar 18, 2023A figure from a review article about #GLP1RA and #SGLT2i33727222422426K26K
SABOURETCardiologist@SABOURETCardioNov 19, 2022Do we need ischemic tests after #ACS or #PCI in asymptomatic pts? #RFcontrol seems more crucial.17176767219219
SABOURETCardiologist@SABOURETCardioMay 7, 2021#CaseReportkazi ferdous@fazalabulJul 11, 2020True or pseudo bit.ly/3247zNI00:0023234343202202
SABOURETCardiologist@SABOURETCardioAug 13, 2021Replying to @SABOURETCardio#Atherosclerosis #lipids #diabetes #inflammation #cardiotwitter888787198198
SABOURETCardiologist@SABOURETCardioMay 18, 2023Online article: how to reduce recurrent #PCI #OutsideOfTheStent during #EuroPCR ☀️1414737320120128K28K
SABOURETCardiologist@SABOURETCardioMar 6, 2021Our article is online ☀️ FREE access #NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View | SpringerLink NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian ViewFrom link.springer.com27277171195195